Inhibition by methylated organoarsenicals of the respiratory 2-oxo-acid dehydrogenases

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Abstract

Inorganic arsenic that is ingested through drinking water or inhalation is metabolized by biological methylation pathways into organoarsenical metabolites. It is now becoming understood that this metabolism that was formerly considered to be detoxification may contribute as much or more to increasing the toxicity of arsenic. One proposed mode of the toxic action of arsenic and its organoarsenic metabolites is through its binding to proteins and inactivating their enzymatic activity. The classic case has been considered the affinity of the proximal 1,3 sulfhydryl groups of the lipoic acid cofactor of the pyruvate dehydrogenase complex for arsenic. A 2:1 stoichiometry of sulfhydryl to arsenic groups has been measured in proteins and arsenical complexes can be synthesized using free d,l-lipoic acid. The relative importance of this site for arsenic binding has come in to question through the use of methylating bifunctional arsenic complexes, and the suggestion that arsenic inhibits the pyruvate dehydrogenase complex indirectly by elevating mitochondrial hydrogen peroxide generation. In order to separate the effects of direct trivalent arsenite toxicity from that of hydrogen peroxide and activated oxygen, we studied the inhibition of the PDH complex under conditions that did not generate hydrogen peroxide but did expose the lipoic acid group in its reduced state to arsenicals. We also studied the effects of arsenicals in the inhibition of the α-ketoglutarate dehydrogenase complex. We found that only trivalent arsenical compounds inhibited the activity of both dehydrogenase complexes and only when the lipoic acid was in its reduced form. Arsenite inhibited both enzyme complexes approximately equivalently while monomethylarsenite inhibited the PDH complex to a greater extent than the KGDH complex - although both complexes were very sensitive to inhibition by this complex. Dimethylarsenite inhibition of both complexes was only observed with longer pre-incubation periods. Cumulative inhibition by the reduced arsenical was observed for all complexes indicating a binding mode of inhibition that is dependent upon lipoic acid being in its reduced state.

Original languageEnglish
Pages (from-to)973-980
Number of pages8
JournalJournal of Organometallic Chemistry
Volume694
Issue number6
DOIs
StatePublished - Mar 15 2009

Funding

This project was funded by NIH Grant No. RR-16455-01 from the BRIN Program of the National Center for Research Resources, Project IBS-CORE Undergraduate Research Fellowship provided by a grant from the Howard Hughes Medical Institute to the University of Montana, Centre for Biomedical Research Excellence (CoBRE) Grant 1P20RR017670, Program Project Three to Andrij Holian and Brooke Martin and National Institute of Environmental Health Sciences Grant Nos. ES10437 and ES014872 to Dr. Kent Sugden. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. Thanks are also due to Drs. Luke and Pam Szweda of Case Western University for the donation of anti-lipoic acid polyclonal antibody and to Dr. Bill Cullen for helpful advice regarding the synthesis of the reduced arsenical species.

FundersFunder number
ES10437, ES014872, 1P20RR017670
RR-16455-01
Howard Hughes Medical Institute

    Keywords

    • Arsenic
    • Lipoic acid
    • Methyl arsenic
    • Pyruvate dehydrogenase
    • α-Ketoglutarate dehydrogenase

    Fingerprint

    Dive into the research topics of 'Inhibition by methylated organoarsenicals of the respiratory 2-oxo-acid dehydrogenases'. Together they form a unique fingerprint.

    Cite this